Growth Metrics

Aligos Therapeutics (ALGS) Change in Acquisitions & Divestments (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Change in Acquisitions & Divestments readings, the most recent being $37.5 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 87.5% to $37.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $127.5 million, a 154.94% increase, with the full-year FY2025 number at $127.5 million, up 41.67% from a year prior.
  • Change in Acquisitions & Divestments hit $37.5 million in Q4 2025 for Aligos Therapeutics, down from $70.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $70.0 million in Q3 2025 to a low of $11000.0 in Q3 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $22.5 million (2023), compared with a mean of $26.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 99.97% in 2023 and later surged 272627.27% in 2024.
  • Aligos Therapeutics' Change in Acquisitions & Divestments stood at $13.0 million in 2021, then soared by 178.62% to $36.2 million in 2022, then crashed by 99.97% to $11000.0 in 2023, then soared by 181718.18% to $20.0 million in 2024, then skyrocketed by 87.5% to $37.5 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $37.5 million (Q4 2025), $70.0 million (Q3 2025), and $20.0 million (Q1 2025) per Business Quant data.